Proteomic analysis of posttranslational modifications using iTRAQ in Leishmania
1Faculty of Biology, Technion-Israel Institute of Technology, Room 504, Haifa, 32000, Israel, danz@bi.technion.ac.il.
Methods in Molecular Biology (Clifton, N.J.)
|November 13, 2014
Summary
This study details iTRAQ (isobaric tag for relative and absolute quantitation) proteomics for analyzing protein abundance and phosphoproteomics in Leishmania parasites. It provides protocols for high-coverage quantitative proteomic analysis.
Area of Science:
- Proteomics
- Molecular Biology
- Parasitology
Background:
- Quantitative proteomics is crucial for understanding cellular processes.
- Isobaric tag for relative and absolute quantitation (iTRAQ) is a powerful technique for multiplexed protein quantification.
- Leishmania parasites present unique challenges for proteomic analysis.
Purpose of the Study:
- To provide detailed protocols for iTRAQ-based protein abundance analysis in Leishmania.
- To establish methods for phosphoproteomics analysis in Leishmania using iTRAQ.
- To enhance the quantitative proteomic capabilities for studying Leishmania.
Main Methods:
- Utilized isobaric tag for relative and absolute quantitation (iTRAQ) labeling of peptides.
- Applied liquid chromatography-tandem mass spectrometry (LC-MS/MS) for peptide separation and identification.
- Developed specific protocols for protein extraction, labeling, and data analysis in Leishmania.
Main Results:
- Demonstrated the capability of iTRAQ to identify and quantify changes in protein abundance across multiple Leishmania samples.
- Successfully applied iTRAQ for phosphoproteomics analysis, identifying key phosphorylation events.
- Achieved identification of nearly 2,000 Leishmania proteins using the iTRAQ-MS/MS assay.
Conclusions:
- iTRAQ is a robust and high-coverage technique for quantitative proteomics in Leishmania.
- The provided protocols facilitate in-depth analysis of protein expression and phosphorylation in these parasites.
- This work significantly advances the study of Leishmania at the proteomic level.


